The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Novel Cell Sorting and Separation Market Research Report 2024
Synopsis
Novel Cell Sorting and Separation refers to techniques that distinguish it from traditional cell screening and isolation. In recent years, extensive research in the field of flow cytometry has enabled the efficient isolation of cells from tissue samples and/or xenogenic cell populations.
The global Novel Cell Sorting and Separation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Novel Cell Sorting and Separation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Novel Cell Sorting and Separation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Novel Cell Sorting and Separation in Cell Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Novel Cell Sorting and Separation include NanoCellect Biomedical, Innovative Biochips, Cesca Therapeutics, Fluidigm, LumaCyte, Union Biometrica, LevitasBio, RareCyte and Cytonome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Novel Cell Sorting and Separation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Cell Sorting and Separation.
Report Scope
The Novel Cell Sorting and Separation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Cell Sorting and Separation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Cell Sorting and Separation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NanoCellect Biomedical
Innovative Biochips
Cesca Therapeutics
Fluidigm
LumaCyte
Union Biometrica
LevitasBio
RareCyte
Cytonome
Namocell
STEMCELL Technologies
Akadeum Life Sciences
QIAGEN
ScreenCell
Segment by Type
Cancer Cell
Immune Cells
Microbial Cell
Red Blood Cell/Platelet
Stem Cell
Other
Segment by Application
Cell Research
Biomedical Diagnosis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Cell Sorting and Separation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Novel Cell Sorting and Separation refers to techniques that distinguish it from traditional cell screening and isolation. In recent years, extensive research in the field of flow cytometry has enabled the efficient isolation of cells from tissue samples and/or xenogenic cell populations.
The global Novel Cell Sorting and Separation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Novel Cell Sorting and Separation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Novel Cell Sorting and Separation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Novel Cell Sorting and Separation in Cell Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Novel Cell Sorting and Separation include NanoCellect Biomedical, Innovative Biochips, Cesca Therapeutics, Fluidigm, LumaCyte, Union Biometrica, LevitasBio, RareCyte and Cytonome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Novel Cell Sorting and Separation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Cell Sorting and Separation.
Report Scope
The Novel Cell Sorting and Separation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Cell Sorting and Separation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Cell Sorting and Separation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NanoCellect Biomedical
Innovative Biochips
Cesca Therapeutics
Fluidigm
LumaCyte
Union Biometrica
LevitasBio
RareCyte
Cytonome
Namocell
STEMCELL Technologies
Akadeum Life Sciences
QIAGEN
ScreenCell
Segment by Type
Cancer Cell
Immune Cells
Microbial Cell
Red Blood Cell/Platelet
Stem Cell
Other
Segment by Application
Cell Research
Biomedical Diagnosis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Cell Sorting and Separation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Cell Sorting and Separation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cancer Cell
1.2.3 Immune Cells
1.2.4 Microbial Cell
1.2.5 Red Blood Cell/Platelet
1.2.6 Stem Cell
1.2.7 Other
1.3 Market by Application
1.3.1 Global Novel Cell Sorting and Separation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cell Research
1.3.3 Biomedical Diagnosis
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Cell Sorting and Separation Market Perspective (2019-2030)
2.2 Novel Cell Sorting and Separation Growth Trends by Region
2.2.1 Global Novel Cell Sorting and Separation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Novel Cell Sorting and Separation Historic Market Size by Region (2019-2024)
2.2.3 Novel Cell Sorting and Separation Forecasted Market Size by Region (2025-2030)
2.3 Novel Cell Sorting and Separation Market Dynamics
2.3.1 Novel Cell Sorting and Separation Industry Trends
2.3.2 Novel Cell Sorting and Separation Market Drivers
2.3.3 Novel Cell Sorting and Separation Market Challenges
2.3.4 Novel Cell Sorting and Separation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Cell Sorting and Separation Players by Revenue
3.1.1 Global Top Novel Cell Sorting and Separation Players by Revenue (2019-2024)
3.1.2 Global Novel Cell Sorting and Separation Revenue Market Share by Players (2019-2024)
3.2 Global Novel Cell Sorting and Separation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Cell Sorting and Separation Revenue
3.4 Global Novel Cell Sorting and Separation Market Concentration Ratio
3.4.1 Global Novel Cell Sorting and Separation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Cell Sorting and Separation Revenue in 2023
3.5 Novel Cell Sorting and Separation Key Players Head office and Area Served
3.6 Key Players Novel Cell Sorting and Separation Product Solution and Service
3.7 Date of Enter into Novel Cell Sorting and Separation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Cell Sorting and Separation Breakdown Data by Type
4.1 Global Novel Cell Sorting and Separation Historic Market Size by Type (2019-2024)
4.2 Global Novel Cell Sorting and Separation Forecasted Market Size by Type (2025-2030)
5 Novel Cell Sorting and Separation Breakdown Data by Application
5.1 Global Novel Cell Sorting and Separation Historic Market Size by Application (2019-2024)
5.2 Global Novel Cell Sorting and Separation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Novel Cell Sorting and Separation Market Size (2019-2030)
6.2 North America Novel Cell Sorting and Separation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Novel Cell Sorting and Separation Market Size by Country (2019-2024)
6.4 North America Novel Cell Sorting and Separation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Cell Sorting and Separation Market Size (2019-2030)
7.2 Europe Novel Cell Sorting and Separation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Novel Cell Sorting and Separation Market Size by Country (2019-2024)
7.4 Europe Novel Cell Sorting and Separation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Cell Sorting and Separation Market Size (2019-2030)
8.2 Asia-Pacific Novel Cell Sorting and Separation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Novel Cell Sorting and Separation Market Size by Region (2019-2024)
8.4 Asia-Pacific Novel Cell Sorting and Separation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Cell Sorting and Separation Market Size (2019-2030)
9.2 Latin America Novel Cell Sorting and Separation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Novel Cell Sorting and Separation Market Size by Country (2019-2024)
9.4 Latin America Novel Cell Sorting and Separation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Cell Sorting and Separation Market Size (2019-2030)
10.2 Middle East & Africa Novel Cell Sorting and Separation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Novel Cell Sorting and Separation Market Size by Country (2019-2024)
10.4 Middle East & Africa Novel Cell Sorting and Separation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NanoCellect Biomedical
11.1.1 NanoCellect Biomedical Company Detail
11.1.2 NanoCellect Biomedical Business Overview
11.1.3 NanoCellect Biomedical Novel Cell Sorting and Separation Introduction
11.1.4 NanoCellect Biomedical Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.1.5 NanoCellect Biomedical Recent Development
11.2 Innovative Biochips
11.2.1 Innovative Biochips Company Detail
11.2.2 Innovative Biochips Business Overview
11.2.3 Innovative Biochips Novel Cell Sorting and Separation Introduction
11.2.4 Innovative Biochips Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.2.5 Innovative Biochips Recent Development
11.3 Cesca Therapeutics
11.3.1 Cesca Therapeutics Company Detail
11.3.2 Cesca Therapeutics Business Overview
11.3.3 Cesca Therapeutics Novel Cell Sorting and Separation Introduction
11.3.4 Cesca Therapeutics Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.3.5 Cesca Therapeutics Recent Development
11.4 Fluidigm
11.4.1 Fluidigm Company Detail
11.4.2 Fluidigm Business Overview
11.4.3 Fluidigm Novel Cell Sorting and Separation Introduction
11.4.4 Fluidigm Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.4.5 Fluidigm Recent Development
11.5 LumaCyte
11.5.1 LumaCyte Company Detail
11.5.2 LumaCyte Business Overview
11.5.3 LumaCyte Novel Cell Sorting and Separation Introduction
11.5.4 LumaCyte Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.5.5 LumaCyte Recent Development
11.6 Union Biometrica
11.6.1 Union Biometrica Company Detail
11.6.2 Union Biometrica Business Overview
11.6.3 Union Biometrica Novel Cell Sorting and Separation Introduction
11.6.4 Union Biometrica Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.6.5 Union Biometrica Recent Development
11.7 LevitasBio
11.7.1 LevitasBio Company Detail
11.7.2 LevitasBio Business Overview
11.7.3 LevitasBio Novel Cell Sorting and Separation Introduction
11.7.4 LevitasBio Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.7.5 LevitasBio Recent Development
11.8 RareCyte
11.8.1 RareCyte Company Detail
11.8.2 RareCyte Business Overview
11.8.3 RareCyte Novel Cell Sorting and Separation Introduction
11.8.4 RareCyte Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.8.5 RareCyte Recent Development
11.9 Cytonome
11.9.1 Cytonome Company Detail
11.9.2 Cytonome Business Overview
11.9.3 Cytonome Novel Cell Sorting and Separation Introduction
11.9.4 Cytonome Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.9.5 Cytonome Recent Development
11.10 Namocell
11.10.1 Namocell Company Detail
11.10.2 Namocell Business Overview
11.10.3 Namocell Novel Cell Sorting and Separation Introduction
11.10.4 Namocell Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.10.5 Namocell Recent Development
11.11 STEMCELL Technologies
11.11.1 STEMCELL Technologies Company Detail
11.11.2 STEMCELL Technologies Business Overview
11.11.3 STEMCELL Technologies Novel Cell Sorting and Separation Introduction
11.11.4 STEMCELL Technologies Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.11.5 STEMCELL Technologies Recent Development
11.12 Akadeum Life Sciences
11.12.1 Akadeum Life Sciences Company Detail
11.12.2 Akadeum Life Sciences Business Overview
11.12.3 Akadeum Life Sciences Novel Cell Sorting and Separation Introduction
11.12.4 Akadeum Life Sciences Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.12.5 Akadeum Life Sciences Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Detail
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Novel Cell Sorting and Separation Introduction
11.13.4 QIAGEN Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.13.5 QIAGEN Recent Development
11.14 ScreenCell
11.14.1 ScreenCell Company Detail
11.14.2 ScreenCell Business Overview
11.14.3 ScreenCell Novel Cell Sorting and Separation Introduction
11.14.4 ScreenCell Revenue in Novel Cell Sorting and Separation Business (2019-2024)
11.14.5 ScreenCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
